Creating VIP Corps to Reduce Maternal Deaths
Violence Intervention and Prevention (VIP) Corps to Reduce Maternal Injuries and Deaths Due to Violence
Ann Coker
2,800 participants
Sep 25, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this observational study is to create and rigorously evaluate a violence intervention and prevention corps (VIP Corps) training using a randomized controlled trial among undergraduate and professional students; and to develop a novel maternal injury surveillance system (MISS) to complement an existing maternal violent death registry in Kentucky.
Eligibility
Inclusion Criteria3
- Students enrolled in a helping professions program
- years of age through 30 years of age
- Students whom will have direct interaction with patients or clients that may experience interpersonal violence (IPV)
Exclusion Criteria3
- Students not enrolled in a helping professions program
- Students under age 18 or over age 30
- Students with no direct interaction with patients or clients
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Our research team has developed an online, interactive learning management system (LMS) training. This training seeks to provide helping professionals with information and resources to identify, intervene, and prevent maternal injuries from interpersonal violence, substance use/disorder (IPV and SU/D). This training will provide healthcare professionals with the knowledge, skills, and efficacy to intervene and build capacity for prevention of maternal injuries and death due to violence.
Implement and evaluate the effectiveness of VIP Corps training aimed at students enrolled in helping professions in their last program year. intervention efficacy to change in students' knowledge, attitudes, and practices of intimate partner violence (IPV) screening, detection, and referrals; participant practices will be the primary, longer-term outcome; while changes in knowledge and attitudes will be short-term outcomes. Secondary outcomes will include changes in detecting symptoms of a) SU/D and b) depression and/or anxiety and providing appropriate resources.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06089109